Skip to main content
Home
  • Home
  • About
    • Who We Are
    • History
    • Governance
      • Board of Members
      • Board of Directors
      • Executive Management
      • Senior Management
    • Principal Investigators
    • Our Capacity
    • Partners
    • Collaborators
    • Sponsors
    • Careers
    • Tenders
      • Policies
    • Research
      • Research Themes
      • Studies
        • Ongoing Studies
        • Completed Studies
      • Laboratory
      • Pharmacy
      • Clinical Research Sites
      • Data Management
      • Regulatory
      • Publications
    • Capacity Building
      • Training
      • Projects
    • Community Engagement
      • Community Engagement Activities
      • Community Advisory Boards
    • Media
      • News
      • Newsletters
      • Press Releases
      • Annual Reports
      • Videos
    • Donate
    Menu

    Studies

    Status:Ongoing

    Find Out More
    The Botswana Epidemiological ART Treatment Cohort Study 2 (2TheBEAT Cohort Study)

    Status:Ongoing

    Find Out More
    A Clinical Trial to Evaluate the Impact of Broadly Neutralizing Antibodies VRC01LS and 10-1074 on Maintenance of HIV Suppression in a Cohort of Early-Treated Children in Botswana (Dual bNAb Treatment in Children)/ Tatelo Study

    Status:Ongoing

    Find Out More
    A cross-sectional evaluation of antibody responses to SARS-COV-2 vaccines

    Status:Ongoing

    Find Out More
    A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Long-acting

    Status:Ongoing

    Find Out More
    A Phase I, Randomized, Placebo-Controlled Study of the Safety, Antiviral & Immunomodulatory Activity of Broadly Neutralizing Antibodies 3BNC117-LS-J and 10-1074-LS-J in Combination in ART-treated Adults in sub-Saharan Africa Living with HIV during a Monit

    Status:Ongoing

    Find Out More
    A Randomized, Double-Blinded, Placebo-Controlled Study of the Combination of Two Long-Acting Broadley Neutralizing Antibodies at ART Initiation in Adults Living With HIV-1 in Sub-Saharan Africa (version 1.0 July 20,2023 for site 12701)

    Status:Ongoing

    Find Out More
    Albuminuria Among Virally Suppressed HIV-infected Patients in Botswana: Longitudinal Changes and Association with Inflammation and ACEI/ARB Use in a Clinical Setting - Albuminuria Study

    Status:Ongoing

    Find Out More
    Aspirin, antenatal micronutrients, and azithromycin (AAA) trial for maximal reduction of preterm birth and related outcomes

    Status:Ongoing

    Find Out More
    Assessment of Proviral Reservoir: Sub study to determine the role of the immune system on the reservoir.

    Status:Ongoing

    Find Out More
    Assessment of Proviral Reservoir: Synergistic combination of reporter cell assay and viral diversity

    Status:Ongoing

    Find Out More
    Birth Outcomes Surveillance Study: Tsepamo Study

    Status:Ongoing

    Find Out More
    Botswana Safe Birth Study

    Status:Ongoing

    Find Out More
    Cellular and humoral immune response in HIV-1-infected children receiving SARS-CoV2-specific mRNA vaccines in Botswana

    Status:Ongoing

    Find Out More
    Characterization of Anthracycline induced Cardiotoxicity Using Cardiac Magnetic Resonance in Botswana: A Prospective Observational study (Pelo Study)

    Status:Ongoing

    Find Out More
    Cognitive Testing of a survey instrument to assess sexual practices, behaviours, and health-related outcomes

    Status:Ongoing

    Find Out More
    Contraceptives and Dolutegravir-based ART (CODA) Study

    Status:Ongoing

    Find Out More
    Doris Duke Study: Adverse Cardiometabolic Impact of Antiretroviral Treatment Regimens Among Pregnant and Post-Partum Women and Their Infants

    Status:Ongoing

    Find Out More
    Dual HIV/syphilis point-of-care testing to improve identification and treatment of syphilis among pregnant women in Gaborone, Botswana

    Status:Ongoing

    Find Out More
    DYNAMICS OF HIV-1 IN RECENTLY DIAGNOSED INDIVIDUALS IN BOTSWANA IN THE ERA OF “TREAT ALL”

    Status:Ongoing

    Find Out More
    Early Infant Treatment Study: A Clinical Trial of HIV Positive Infants in Botswana

    Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Next page Next ›
    • Last page Last »

    Media

    BHP Meets Vice President Gaolathe
    April 10, 2025
    BHP Meets Vice President Gaolathe
    Dr Wonderful Choga
    March 27, 2025
    2024 – 2025 Harvard Global Health Institute Visiting Scholars
    BHP strategy team
    January 28, 2025
    BHP holds two-day Strategy Retreat to shape Strategic Plan
    Dr Makhema and Hon. Minister Modise
    January 27, 2025
    BHP meets the new Minister of Health
    View All

    footer.png

     

    Botswana Harvard Health Partnership
    Princess Marina Hospital
    Plot No. 1836, Northring Road, Gaborone, Botswana
    Email: info@bhp.org.bw
    Tel: +267 3902671

    • f
    • t
    • l
    • y
    • Contact Us
    • Laboratory
    • Research Papers
    • Ongoing Studies
    • Register for Study Participation

    All Rights Reserved. Botswana Harvard Health Partnership © 2022

    Website Design and Development - MindQ

    • Home
    • About
      • Who We Are
      • History
      • Governance
        • Board of Members
        • Board of Directors
        • Executive Management
        • Senior Management
      • Principal Investigators
      • Our Capacity
      • Partners
      • Collaborators
      • Sponsors
      • Careers
      • Tenders
      • Policies
    • Research
      • Research Themes
      • Studies
        • Ongoing Studies
        • Completed Studies
      • Laboratory
      • Pharmacy
      • Clinical Research Sites
      • Data Management
      • Regulatory
      • Publications
    • Capacity Building
      • Training
      • Projects
    • Community Engagement
      • Community Engagement Activities
      • Community Advisory Boards
    • Media
      • News
      • Newsletters
      • Press Releases
      • Annual Reports
      • Videos
    • Donate